Find clinical trials for Multiple Myeloma in Cleveland, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Cleveland, OH, USA:
The purpose of this study is to assess the safety, tolerability, preliminary efficacy, cellular kinetics, and other exploratory endpoints of AZD4045...
Phase 1, Phase 2
Cleveland, Ohio, United States and 11 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Cleveland, Ohio, United States and 107 other locations
of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longe...
Phase 1
Cleveland, Ohio, United States and 15 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Cleveland, Ohio, United States and 211 other locations
in combination with pomalidomide and dexamethasone, in patients with multiple myeloma that has come back following treatment and wh...
Phase 2
Cleveland, Ohio, United States and 19 other locations
Relapsed Refractory Multiple Myeloma and CC-220 in combination with DEX and BTZ for Newly Diagnosed Multiple Myeloma...
Phase 1, Phase 2
Cleveland, Ohio, United States and 161 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
Cleveland, Ohio, United States and 265 other locations
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...
Phase 3
Cleveland, Ohio, United States and 165 other locations
A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexa...
Phase 3
Cleveland, Ohio, United States and 182 other locations
in combination with Pd/DRd in patients with relapsed/refractory (RR) multiple myeloma (MM). The study consists of dose escalation a...
Phase 1, Phase 2
Cleveland, Ohio, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal